Company Data

Larimar Therapeutics Inc.

Ticker
LRMR
Current Price
$3.34 2.14%
Market Cap
$213.1M
Price Target
Refer to Report
Volume
330.0K
52wk Range
$3.01 - $13.68
Advanced Market Data

Overview

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich’s ataxia.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy